← All stocks

Cadrenal Therapeutics, Inc.

CVKD Net selling
CIK 0001937993 #5392 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$999.75K
$929.40K on a plan · $0.00 straight out of an exercise
Sold at will
$70.35K
3 of 41 sales
Net
−$999.75K
−$70.35K against sales at will

By person

2 insiders · 41 transactions
0.3×

Quang X. Pham holds only 0.3 times base salary in stock. $298.72K of shares against $751.28K in salary for 2025.

Salary from the company's own proxy. The shares are what Quang X. Pham last reported holding, valued at $3.03, the price Common Stock was last bought or sold at on the open market here, on 29 Jun 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Pham Quang X
Chairman and CEO
$630.29K (31) scheduled
−$630.29K
98,589
$298.72K
−54.8%
Szot Matthew K
Chief Financial Officer
$369.46K (10) scheduled
−$369.46K
0
$0.00
−100.0%

No percentages here. This company's share count has moved by a factor of 2.2 over the window, from 1,658,771 to 3,567,592 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 22
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 38
Sales straight out of an exercise 0
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 0
History held since 24 Jan 2023